BPC-157 is not an FDA-approved medication for pain, injury recovery, gastrointestinal conditions, inflammation, or another human medical indication
Cysteine is frequently identified as rate-limiting, or limiting the ability of glutathione synthesis based on lack of availability
Skin improvements tend to become visible earliest, while hair growth requires the most patience
Further, we can assume that the neuromuscular junction function is a needed precondition that BPC 157 therapy (effective in rat injury, given intraperitoneally or in drinking water or topically, at the site of injury) induces the healing of the transected muscle [71], crushed muscle [72], denervated muscle [73], and myotendinous junction [74]
The additional acetyl group stabilises the S-acetyl glutathione, allowing it to be better absorbed
The GHK-Cu injection is one of the main ways to provide your body with GHK-Cu